AMT-253 in Patients With Selected Advanced Solid Tumours

NCT05906862 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: AMT-253

Sponsor

Multitude Therapeutics (Australia) Pty Ltd